Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLIN-HEALTH: Sex Steroids Balance in Men With Klinefelter Syndrome
NCT05586802Phase 3Recruiting
- Start
- Mar 2023
- Primary completion
- Apr 2027
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of anastrozole, semaglutide buccal patch (BUCCAL-PEP) in Klinefelter syndrome (KS). Started Mar 2023; status: recruiting.
02
Drugs
anastrozolesemaglutide buccal patch (BUCCAL-PEP)
03
Conditions
Klinefelter syndrome (KS)
Beyond the preview
Go deeper on NCT05586802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586802.